Braun Bostich & Associates Inc. Gsk PLC Transaction History

Braun Bostich & Associates Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 09, 2020	SELL	$38.11 - $42.99 $15,244 - $17,196	-400 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$42.0 - $48.25 $16,800 - $19,300	400 New	400 $19,000
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $64,210 - $69,066	-1,587 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $13,474 - $14,603	-342 Reduced 17.73%	1,587 $64,000
Q4 2018 Feb 08, 2019	SELL	$37.8 - $42.69 $19,882 - $22,454	-526 Reduced 21.43%	1,929 $74,000
Q1 2018 May 16, 2018	SELL	$36.18 - $40.15 $44,211 - $49,063	-1,222 Reduced 33.23%	2,455 $0
Q4 2017 May 21, 2018	BUY	$35.34 - $41.9 $129,945 - $154,066	3,677	3,677 $130,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Braun Bostich & Associates Inc., based on Form 13F filings with the SEC.

Stay updated on Braun Bostich & Associates Inc. with notifications on news.